PHS
TWST icon

Pekin Hardy Strauss’s Twist Bioscience TWST Stock Holding History

Pekin Hardy Strauss’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.41M Sell
23,400
-8,375
-26% -$545K 0.21% 123
2026
Q1 		$1.51M Buy
31,775
+17,325
+120% +$777K 0.16% 161
2025
Q4 		$458K Buy
+14,450
New +$451K 0.04% 290

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Pekin Hardy Strauss's TWST Position: Q2 2026 in Review

Pekin Hardy Strauss reduced its Twist Bioscience (TWST) stake by 26% in Q2 2026, selling an estimated $545K and leaving 23,400 shares worth $2.41M. The position accounts for 0.21% of the portfolio, ranked #123.

Pekin Hardy Strauss first reported a position in TWST in Q4 2025 and has held it in 3 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Pekin Hardy Strauss held 23,400 shares of Twist Bioscience worth $2.41M as of Q2 2026.
  • Pekin Hardy Strauss sold 8,375 Twist Bioscience shares in Q2 2026, an estimated $545K.
  • Twist Bioscience made up 0.21% of Pekin Hardy Strauss's portfolio in Q2 2026, its #123 holding.
  • Pekin Hardy Strauss first reported a position in Twist Bioscience in Q4 2025 and has held it in 3 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Pekin Hardy Strauss's 13F filing for Q2 2026, filed 30 Jul 2026.